BMPR2 and pulmonary arterial hypertension: Moreover, bone morphogenetic protein receptor type 2 (BMPR2) mutations alter insulin signaling and glucose metabolism in H9c2 cardiomyocytes (116), which links heritable PAH to metabolic RV derangements.